134 related articles for article (PubMed ID: 38677442)
1. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel ligand binding assay for relaxin family peptide receptor 3 and 4 using NanoLuc complementation.
Hu MJ; Shao XX; Li HZ; Nie WH; Wang JH; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2018 Aug; 50(8):1111-1119. PubMed ID: 29770870
[TBL] [Abstract][Full Text] [Related]
3. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
4. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.
Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY
J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726
[TBL] [Abstract][Full Text] [Related]
5. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids.
Wang JH; Hu MJ; Zhang L; Shao XX; Lv CH; Liu YL; Xu ZG; Guo ZY
Biochimie; 2018 Nov; 154():77-85. PubMed ID: 30102931
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.
Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393
[TBL] [Abstract][Full Text] [Related]
7. Functionality of an absolutely conserved glycine residue in the chimeric relaxin family peptide R3/I5.
Wang JH; Shao XX; Hu MJ; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2019 Apr; 51(4):619-626. PubMed ID: 30604098
[TBL] [Abstract][Full Text] [Related]
8. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
[TBL] [Abstract][Full Text] [Related]
9. Rapid preparation of bioluminescent tracers for relaxin family peptides using sortase-catalysed ligation.
Wang JH; Shao XX; Hu MJ; Wei D; Nie WH; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2017 Sep; 49(9):1611-1617. PubMed ID: 28631012
[TBL] [Abstract][Full Text] [Related]
10. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
[TBL] [Abstract][Full Text] [Related]
11. Exploring electrostatic interactions of relaxin family peptide receptor 3 and 4 with ligands using a NanoBiT-based binding assay.
Wang JH; Nie WH; Shao XX; Li HZ; Hu MJ; Liu YL; Xu ZG; Guo ZY
Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):776-786. PubMed ID: 30684458
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobic interactions of relaxin family peptide receptor 3 with ligands identified using a NanoBiT-based binding assay.
Li HZ; Li N; Shao XX; Liu YL; Xu ZG; Guo ZY
Biochimie; 2020 Oct; 177():117-126. PubMed ID: 32810565
[TBL] [Abstract][Full Text] [Related]
13. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
14. Engineering of chimeric peptides as antagonists for the G protein-coupled receptor, RXFP4.
Praveen P; Bathgate RAD; Hossain MA
Sci Rep; 2019 Nov; 9(1):17828. PubMed ID: 31780677
[TBL] [Abstract][Full Text] [Related]
15. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
16. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.
Kuei C; Sutton S; Bonaventure P; Pudiak C; Shelton J; Zhu J; Nepomuceno D; Wu J; Chen J; Kamme F; Seierstad M; Hack MD; Bathgate RA; Hossain MA; Wade JD; Atack J; Lovenberg TW; Liu C
J Biol Chem; 2007 Aug; 282(35):25425-35. PubMed ID: 17606621
[TBL] [Abstract][Full Text] [Related]
17. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions.
Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977
[TBL] [Abstract][Full Text] [Related]
18. Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus.
Ganella DE; Callander GE; Ma S; Bye CR; Gundlach AL; Bathgate RA
Gene Ther; 2013 Jul; 20(7):703-16. PubMed ID: 23135160
[TBL] [Abstract][Full Text] [Related]
19. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation.
Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY
FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration.
DeChristopher B; Park SH; Vong L; Bamford D; Cho HH; Duvadie R; Fedolak A; Hogan C; Honda T; Pandey P; Rozhitskaya O; Su L; Tomlinson E; Wallace I
Bioorg Med Chem Lett; 2019 Apr; 29(8):991-994. PubMed ID: 30824200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]